A COVID-19 “immunity passport” is still just an idea, as there is not enough evidence to show that people who have contracted the disease will have permanent immunity, a biomedical specialist said yesterday.
Shih Shin-ru (施信如), director of Chang Gung University’s Research Center for Emerging Viral Infections and a member of the Central Epidemic Command Center’s specialist advisory panel, gave a speech on the idea of “immunity passports” at a conference on diagnostic tests for SARS-CoV-2 in Taipei.
The conference, held at National Taiwan University’s College of Medicine, was organized by the Taiwan Society of Microbiology, the Taiwan Society of Clinical Pathologists, and the Society of Taiwan Long-Term Care Infection Prevention and Control at National Taiwan University’s College of Medicine.
COVID-19 has only been around for a few months, so no one yet knows its long-term health effects, or who would only have mild symptoms, as people of all ages and health conditions have died from it, Shih said, adding US National Institute of Allergy and Infectious Diseases Director Anthony Fauci’s comment, “we literally ‘do not know’ what we do not know.”
The idea of testing authorities issuing a COVID-19 “immunity passport” or certificate after serology tests demonstrate that the bearer has antibodies making them immune to the disease as a way of boosting economic recovery and international travel has gained popularity, she said.
Five factors that should be considered before issuing such a passport include whether “recovered patients have protective immunity that prevents them from being re-infected,” Shih said.
However, so far COVID-19 studies have not been able to prove there is protective immunity from the disease, as some recovered patients have tested positive again, and whether they were re-infected or the virus had not been eliminated from their body is still not clear, she said.
Another factor would need to be that “the protective immunity is long-lasting,” but immunity from other types of coronaviruses has not lasted very long, and specialists in many nations think immunity to SARS-CoV-2 might be able to last about six months, based on the fact that neutralizing antibodies against the virus can still be found in recovered patients who contracted the disease in January, she said.
Given that the WHO on April 24 said that “there is not enough evidence about the effectiveness of antibody-mediated immunity to guarantee the accuracy of an ‘immunity passport,’” there are also ethical concerns that issuing an immunity certificate for work or travel could force people to take tests or risk losing their jobs, or even create an incentive for people to intentionally get infected, Shih said.
More studies are needed to understand whether recovered COVID-19 patients are immune to secondary infection, she said.
BY OTHER MEANS: China could see CPTPP membership as a means of circumventing trade restrictions imposed by the US, amid an ongoing trade dispute between them The US could invoke a clause in its trade agreement with Canada and Mexico to block China’s application to join the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), a government official said yesterday. Under Article 32.10 of the Exceptions and General Provisions of the United States-Mexico-Canada Agreement (USMCA), if either Canada or Mexico enter a free-trade agreement with a nonmarket economy — such as China — the US could withdraw from the agreement. “If that clause applies to multilateral free-trade agreements such as the CPTPP — which Mexico and Canada are members of — that might be cause for the two
National Taiwan University Hospital’s (NTUH) Ethical Review Committee on Tuesday approved the hospital’s application to conduct human trials of mixed Moderna and Medigen COVID-19 vaccines. The hospital yesterday said that 220 volunteers aged 20 to 70 who have received one dose of a Moderna vaccine eight to 12 weeks ago are to be enrolled in the program. The volunteers are to be separated into two groups — a treatment group and a control group — and a double-blind study would be conducted, assigning Medigen or Moderna vaccines to the groups on a random basis, it said. The trial is expected to start
AT ODDS: The KMT called on the government to seek bilateral dialogue with Beijing to resolve the issue that led to the ban on custard apple and wax apple imports Democratic Progressive Party (DPP) officials and lawmakers yesterday condemned China’s sudden ban on imports of custard apples and wax apples from Taiwan as “obvious political retaliation,” while the opposition called for a scientific investigation into Beijing’s claim to have found pests in imports of the fruits. China earlier yesterday announced a ban on the importation of the two fruits from today, citing repeated discoveries of Planococcus minor, a type of mealybug. The announcement follows a similar ban on Taiwanese pineapples imposed in February. At least Beijing gave a few days’ notice when it banned pineapple imports, an unnamed government official said yesterday. This time
TAIWAN TIES: The foreign ministry said like-minded nations continue to express support for Taiwan’s ties with Lithuania, highlighting a letter by Slovenia’s PM US Secretary of State Antony Blinken on Wednesday saluted Lithuania’s championing of democracy in Taiwan and Belarus. Lithuania in July agreed to let Taiwan open a representative office using its own name, prompting a pressure campaign by China. “We stand against economic coercion, including that being exerted by China,” Blinken said as he welcomed Lithuanian Minister of Foreign Affairs Gabrielius Landsbergis in Washington. “We stand strongly for democracy, including in Belarus, where we’re very much working together,” Blinken said. Landsbergis told reporters afterward that he and Blinken discussed “economic, financial, political measures” that can be taken to withstand Chinese pressure. “We discussed various possible measures